Hypocretin and receptors

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: ==Your Heading Here (maybe something like 'Structure')== <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> This is a default text for you...)
Line 1: Line 1:
==Your Heading Here (maybe something like 'Structure')==
==Your Heading Here (maybe something like 'Structure')==
-
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
+
<StructureSection load='1cq0' size='340' side='right' caption='Caption for this structure' scene=''>
This is a default text for your page '''Hypocretin and Receptors'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
This is a default text for your page '''Hypocretin and Receptors'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
Line 10: Line 10:
Orexin-A and Orexin-B bind with corresponding G-protein-coupled receptors known as OX1R and OX2R. While both OX1R and OX2R can be found within the brains of mammals, OX1R and OX2R are distributed throughout the brain in varying amounts at different locations. OX1R and OX2R, both, have an alpha-helix in their extracellular N-terminal regions. The N-terminal alpha-helixes serve a critical roll in Orexin-A-mediated neuropeptide activation. Although the structures of the N-terminal alpha helixes of both OX1R and OX2R are similar, the orientation varies between the two receptors. While the N-terminal alpha-helix of OX1R is found to interact with the extracellular loop 2 (ECL2), the N-terminal alpha-helix of OX2R is found to be parallel to the helix 8 on the intracellular side of the membrane. Residues at 2.61 and 3.33 in both OX1R and OX2R play a critical roll in determining the subtype selectivity. Orexin receptors produce neuroexcitation through postsynaptic depolarization by activating non-selective cation channels, inhibiting K+ channels, and activating Na+/Ca2+ exchange. Additionally, OX1R and OX2R stimulate the release of neurotransmitters through presynaptic actions, and OX1R and OX2R modulate synaptic plasticity. Both Orexin receptors have been shown to couple strongly with Ca2+ ion elevations and phospholipase C. Low concentrations of Orexin causes OX1R stimulation, activating a Ca2+ influx. It has been indicated, directly or indirectly, that OX1R and OX2R can couple to Gq, Gi/o and Gs, three of the four heterotrimeric G-protein families. Studies have also revealed that OX2R can couple differently to Gq, Gi/o and Gs proteins depending on which of the various possible types of tissues OX2R can be found in, the OX2R resides within. Since OX1R and OX2R play important rolls in sleep regulation, sleep disorders, such as narcolepsy, can been caused by mutations of these regulators. Narcolepsy, specifically type 1 narcolepsy, can be caused by mutation of the OX2R gene (HCRTR2).
Orexin-A and Orexin-B bind with corresponding G-protein-coupled receptors known as OX1R and OX2R. While both OX1R and OX2R can be found within the brains of mammals, OX1R and OX2R are distributed throughout the brain in varying amounts at different locations. OX1R and OX2R, both, have an alpha-helix in their extracellular N-terminal regions. The N-terminal alpha-helixes serve a critical roll in Orexin-A-mediated neuropeptide activation. Although the structures of the N-terminal alpha helixes of both OX1R and OX2R are similar, the orientation varies between the two receptors. While the N-terminal alpha-helix of OX1R is found to interact with the extracellular loop 2 (ECL2), the N-terminal alpha-helix of OX2R is found to be parallel to the helix 8 on the intracellular side of the membrane. Residues at 2.61 and 3.33 in both OX1R and OX2R play a critical roll in determining the subtype selectivity. Orexin receptors produce neuroexcitation through postsynaptic depolarization by activating non-selective cation channels, inhibiting K+ channels, and activating Na+/Ca2+ exchange. Additionally, OX1R and OX2R stimulate the release of neurotransmitters through presynaptic actions, and OX1R and OX2R modulate synaptic plasticity. Both Orexin receptors have been shown to couple strongly with Ca2+ ion elevations and phospholipase C. Low concentrations of Orexin causes OX1R stimulation, activating a Ca2+ influx. It has been indicated, directly or indirectly, that OX1R and OX2R can couple to Gq, Gi/o and Gs, three of the four heterotrimeric G-protein families. Studies have also revealed that OX2R can couple differently to Gq, Gi/o and Gs proteins depending on which of the various possible types of tissues OX2R can be found in, the OX2R resides within. Since OX1R and OX2R play important rolls in sleep regulation, sleep disorders, such as narcolepsy, can been caused by mutations of these regulators. Narcolepsy, specifically type 1 narcolepsy, can be caused by mutation of the OX2R gene (HCRTR2).
 +
=='''Functions'''==
== Sleep-wake Regulation ==
== Sleep-wake Regulation ==
Low amounts of Orexin and mutations of the OX2R gene (HCRTR2) have been linked to the development of narcolepsy, a sleep disorder characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations. Cataplexy, the loss of muscle tone, hypnagogic hallucinations, hallucinations produced while an individual is falling asleep, and sleep paralysis, the immobilization of an individual’s body while falling or waking from sleep, are thought to be caused when REM sleep is unexpectedly interrupted. Narcolepsy causes a lack of regulation of the sleep/wake cycle, and, thus, narcolepsy frequently causes both interruptions of a person’s wakefulness and a person’s REM sleep. Orexin interacts with several wake-promoting neuronal groups, such as the histaminergic neurons of the tuberomammilary nucleus and the noradrenergic neurons of the locus coeruleus. The locus coeruleus is a structure in the brainstem that produces the neurotransmitter norepinephrine. Therefore, it can be concluded that when Orexin neurons are stimulated the possibility of transitioning to a state of wakefulness increases. However, if Orexin neurons are inhibited the probability of transitioning to sleeping state increases. Narcolepsy is also characterized by fragmented sleep, which is sleep interrupted by many brief periods of arousal. Fragmented sleep is caused by the instability of behavioral state regulation due to the lack of Orexin lowering the thresholds required to transition between sleep and wakefulness. Since narcoleptic individuals tends to fall asleep during the day, but wake up repeatedly at night, it is likely that Orexin functions as a way to stabilize the transition between sleep and wake states, as well as causing the transition between the states.
Low amounts of Orexin and mutations of the OX2R gene (HCRTR2) have been linked to the development of narcolepsy, a sleep disorder characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations. Cataplexy, the loss of muscle tone, hypnagogic hallucinations, hallucinations produced while an individual is falling asleep, and sleep paralysis, the immobilization of an individual’s body while falling or waking from sleep, are thought to be caused when REM sleep is unexpectedly interrupted. Narcolepsy causes a lack of regulation of the sleep/wake cycle, and, thus, narcolepsy frequently causes both interruptions of a person’s wakefulness and a person’s REM sleep. Orexin interacts with several wake-promoting neuronal groups, such as the histaminergic neurons of the tuberomammilary nucleus and the noradrenergic neurons of the locus coeruleus. The locus coeruleus is a structure in the brainstem that produces the neurotransmitter norepinephrine. Therefore, it can be concluded that when Orexin neurons are stimulated the possibility of transitioning to a state of wakefulness increases. However, if Orexin neurons are inhibited the probability of transitioning to sleeping state increases. Narcolepsy is also characterized by fragmented sleep, which is sleep interrupted by many brief periods of arousal. Fragmented sleep is caused by the instability of behavioral state regulation due to the lack of Orexin lowering the thresholds required to transition between sleep and wakefulness. Since narcoleptic individuals tends to fall asleep during the day, but wake up repeatedly at night, it is likely that Orexin functions as a way to stabilize the transition between sleep and wake states, as well as causing the transition between the states.

Revision as of 15:12, 24 April 2019

Your Heading Here (maybe something like 'Structure')

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644

Proteopedia Page Contributors and Editors (what is this?)

Alex Ogden, Alexander Berchansky, Michal Harel

Personal tools